Nykode Therapeutics AS Ratios and Metrics

Market cap in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	1,104	790	1,000	6,926	8,303	23,376
Market Cap Growth	94.03%	-20.93%	-85.57%	-16.58%	-64.48%	8.14%
Enterprise Value	626.99	207.84	-275.48	5,330	6,340	21,425
Last Close Price	3.38	2.42	3.06	21.21	28.17	80.71
Forward PE	-	24.28	24.28	24.28	23.99	4.32
PS Ratio	203.83	172.94	9.58	51.10	94.11	74.12
PB Ratio	1.29	0.86	0.64	3.98	5.41	13.66
P/TBV Ratio	12.07	8.64	7.34	37.24	52.07	119.12
P/FCF Ratio	-	-	-	-	-	9334.41
P/OCF Ratio	-	-	-	-	-	2295.21
EV/Sales Ratio	115.79	45.48	-2.64	39.32	71.86	67.93
EV/EBITDA Ratio	-	-	0.52	-	-	-
EV/EBIT Ratio	-	-	0.50	-	-	-
EV/FCF Ratio	-	-	0.47	-	-	8555.43
Debt / Equity Ratio	0.01	0.01	0.02	0.02	0.03	0.03
Debt / FCF Ratio	-	-	-	-	-	25.25
Net Debt / Equity Ratio	-0.63	-0.63	-0.82	-0.92	-1.28	-1.14
Net Debt / EBITDA Ratio	2.17	2.17	2.43	2.80	3.91	22.03
Net Debt / FCF Ratio	1.96	1.96	2.18	1.59	8.60	-778.98
Asset Turnover	0.00	0.00	0.05	0.06	0.04	0.14
Quick Ratio	10.00	10.00	12.87	8.04	5.43	8.16
Current Ratio	10.00	10.00	12.87	8.04	5.43	8.16
Return on Equity (ROE)	-10.75%	-10.75%	-25.25%	-21.42%	-24.35%	-5.05%
Return on Assets (ROA)	-15.60%	-15.60%	-22.80%	-21.56%	-18.30%	-3.68%
Return on Invested Capital (ROIC)	-54.91%	-68.12%	-213.40%	-	-	-
Return on Capital Employed (ROCE)	-24.01%	-24.01%	-29.12%	-31.39%	-25.51%	-4.78%
FCF Yield	-	-	-	-	-	0.01%
Dividend Yield	29.85%	41.20%	0.00%	0.00%	0.00%	0.00%
Payout Ratio	-	-263.72%	0.00%	0.00%	0.00%	0.00%
Buyback Yield / Dilution	-	0.00%	-8.66%	-3.59%	-1.32%	3.31%
Total Shareholder Return	29.85%	41.20%	-8.66%	-3.59%	-1.32%	3.31%